# Reborn Coffee, Inc.: overview

REBN · Nasdaq · CIK 1707910 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rebn.md) · [Financials](/companies/rebn/financials.md) · [Filings](/companies/rebn/filings.md) · [Insiders](/companies/rebn/insiders.md)

Latest reported revenue: [$6.3m](/filings/0001213900-26-099791.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Sep 14, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-099791).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,259](/filings/0001213900-25-112680.md) | [1,779 d](/filings/0001213900-26-046490.md) | [1,693](/filings/0001213900-26-060633.md) | [1,835](/filings/0001213900-26-099791.md) | [1,357](/filings/0001213900-25-112680.md) | [3,210 d](/filings/0001213900-26-046490.md) | [5,211](/filings/0001213900-26-060633.md) | [6,322](/filings/0001213900-26-099791.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(57.6%)](/filings/0001213900-25-112680.md) | [(95.2%) d](/filings/0001213900-26-046490.md) | [(100.2%)](/filings/0001213900-26-060633.md) | [(240.2%)](/filings/0001213900-26-099791.md) | [(224.7%)](/filings/0001213900-25-112680.md) | [104.6% d](/filings/0001213900-26-046490.md) | [(16.7%)](/filings/0001213900-26-060633.md) | [(24.9%)](/filings/0001213900-26-099791.md) |
| Net margin | % | [(57.2%)](/filings/0001213900-25-112680.md) | [(100.0%) d](/filings/0001213900-26-046490.md) | [(129.4%)](/filings/0001213900-26-060633.md) | [(291.0%)](/filings/0001213900-26-099791.md) | [(254.3%)](/filings/0001213900-25-112680.md) | [57.3% d](/filings/0001213900-26-046490.md) | [(35.1%)](/filings/0001213900-26-060633.md) | [(41.3%)](/filings/0001213900-26-099791.md) |
| Diluted EPS | $ per share | [(0.30)](/filings/0001213900-25-112680.md) | not reported | [(0.47)](/filings/0001213900-25-046026.md) | [(1.15)](/filings/0001213900-26-099791.md) | [(0.68)](/filings/0001213900-25-112680.md) | not reported | not reported | [(0.32)](/filings/0001213900-26-099791.md) |
| Free cash flow | $k | [(424) d](/filings/0001213900-25-112680.md) | [(601) d](/filings/0001213900-26-046490.md) | not reported | not reported | [(1,621) d](/filings/0001213900-25-112680.md) | [(1,745) d](/filings/0001213900-26-046490.md) | [224](/filings/0001213900-26-060633.md) | [(2,064) d](/filings/0001213900-26-099791.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,280](/filings/0001213900-23-028895.md) | [3,241](/filings/0001213900-24-026917.md) | [5,508](/filings/0001213900-25-026307.md) | [5,929](/filings/0001213900-26-046490.md) | [8,095](/filings/0001213900-26-046490.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(112.4%)](/filings/0001213900-23-028895.md) | [(109.3%)](/filings/0001213900-24-026917.md) | [(82.5%)](/filings/0001213900-25-026307.md) | [(77.9%)](/filings/0001213900-26-046490.md) | [(71.6%)](/filings/0001213900-26-046490.md) |
| Net margin | % | [(150.9%)](/filings/0001213900-23-028895.md) | [(109.7%)](/filings/0001213900-24-026917.md) | [(85.8%)](/filings/0001213900-25-026307.md) | [(81.1%)](/filings/0001213900-26-046490.md) | [(112.9%)](/filings/0001213900-26-046490.md) |
| Diluted EPS | $ per share | [(0.32)](/filings/0001213900-23-028895.md) | [(0.29)](/filings/0001213900-24-026917.md) | [(2.86)](/filings/0001213900-25-026307.md) | [(1.66)](/filings/0001213900-26-046490.md) | [(1.73)](/filings/0001213900-26-046490.md) |
| Free cash flow | $k | [(2,298)](/filings/0001213900-23-028895.md) | [(3,979)](/filings/0001213900-24-026917.md) | [(5,592)](/filings/0001213900-25-026307.md) | [(4,562)](/filings/0001213900-26-046490.md) | [(6,557)](/filings/0001213900-26-046490.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rebn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $78.9k | 52,257 |  | New +52,257 |
| [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $69.4k | 45,934 |  | Added +35,587 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $56.5k | 37,404 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $34.3k | 22,709 |  | Unchanged |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $23.1k | 15,292 |  | New +15,292 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $911 | 603 |  | New +603 |
| [BARCLAYS PLC](/funds/312069.md) | 2026-06-30 | $248 | 164 |  | New +164 |
| [Caitong International Asset Management Co., Ltd](/funds/1963355.md) | 2026-06-30 | $38 | 25 |  | Added +24 |

## Recent filings

[All 201 filings](/companies/rebn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 23:32 ET | [8-K](/filings/0001213900-26-111434.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-111434 |
| 2026-09-22 | 20:17 ET | [8-K](/filings/0001213900-26-102200.md) | 3.01 Delisting notice | 0001213900-26-102200 |
| 2026-09-14 | 21:25 ET | [10-Q](/filings/0001213900-26-099791.md) | Quarterly report, period 2026-06-30 | 0001213900-26-099791 |
| 2026-09-10 | 20:26 ET | [8-K](/filings/0001213900-26-098812.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-098812 |
| 2026-09-02 | 20:59 ET | [8-K](/filings/0001213900-26-096775.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-096775 |
| 2026-08-12 | 00:24 ET | [8-K](/filings/0001213900-26-087943.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-087943 |
| 2026-06-16 | 20:26 ET | [8-K/A](/filings/0001213900-26-069278.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-069278 |
| 2026-06-10 | 22:20 ET | [8-K](/filings/0001213900-26-066926.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-066926 |
| 2026-05-22 | 20:46 ET | [10-Q](/filings/0001213900-26-060633.md) | Quarterly report, period 2026-03-31 | 0001213900-26-060633 |
| 2026-05-05 | 19:46 ET | [8-K](/filings/0001213900-26-052154.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-052154 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-046490.md), filed Apr 22, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/57867755-3097-41b8-9271-62db4abec5f7)

## About the filer

- CIK: 1707910
- Tickers: REBN
- Exchange: Nasdaq
- SIC code: 5812 Retail-Eating  Places
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.
